Valuation : BOIRON

Market Cap 45Cr 52Cr 43Cr 39Cr 73Cr 5.01TCr 73Cr 507.66Cr 195.22Cr 2.55TCr 196.77Cr 192.45Cr 8.05TCr P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 40Cr 47Cr 38Cr 35Cr 65Cr 4.47TCr 65Cr 453.84Cr 174.52Cr 2.28TCr 175.91Cr 172.05Cr 7.19TCr EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 week+0.77%
Current month+0.77%
1 month-1.51%
3 months-7.45%
6 months-0.95%
Current year-12.42%
1 week 25.9
Extreme 25.9
26.1
1 month 25.7
Extreme 25.7
26.5
3 years 20.5
Extreme 20.5
55.9
5 years 20.5
Extreme 20.5
55.9
10 years 20.5
Extreme 20.5
91.9
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2025
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Chairman 65 01/07/2011
Director/Board Member 54 10/03/2010
Director/Board Member 51 23/05/2013
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.77%+11.06%-51.12% 52Cr
0.00%-1.22%-14.56%-5.64% 1.34TCr
-1.27%-3.07%-33.48%-56.88% 478.37Cr
-0.61%-5.58%-5.83%-6.20% 436.08Cr
-1.49%-4.28%-11.69%-32.46% 378.29Cr
-1.37%-3.98%-25.66%+0.79% 343.03Cr
-2.78%-3.65%-4.32%-5.13% 340.71Cr
-0.85%-4.82%-13.72%+3.39% 312.21Cr
-1.30%-2.63%-24.61%-18.99% 227.3Cr
-2.13%-2.81%-29.80%-20.08% 163.42Cr
Average -1.31%-2.87%-15.26%-19.23% 446.65Cr
Weighted average by Cap. -0.94%-2.27%-16.44%-14.84%

Financials

2024 2025
Net sales 49Cr 57Cr 46Cr 42Cr 79Cr 5.41TCr 79Cr 548.3Cr 210.85Cr 2.75TCr 212.52Cr 207.86Cr 8.69TCr 50Cr 58Cr 47Cr 43Cr 81Cr 5.56TCr 81Cr 563.53Cr 216.7Cr 2.83TCr 218.43Cr 213.63Cr 8.93TCr
Net income 1.13Cr 1.32Cr 1.07Cr 97.29L 1.83Cr 125.7Cr 1.83Cr 13Cr 4.9Cr 64Cr 4.94Cr 4.83Cr 202.07Cr 3.26Cr 3.79Cr 3.09Cr 2.8Cr 5.26Cr 361.95Cr 5.28Cr 37Cr 14Cr 184.14Cr 14Cr 14Cr 581.88Cr
Net Debt -4.97Cr -5.77Cr -4.71Cr -4.27Cr -8.01Cr -551.5Cr -8.05Cr -56Cr -22Cr -280.58Cr -22Cr -21Cr -886.6Cr -4.79Cr -5.55Cr -4.53Cr -4.11Cr -7.71Cr -530.62Cr -7.74Cr -54Cr -21Cr -269.96Cr -21Cr -20Cr -853.04Cr
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
-
Date Price Change
11/26/11 €26.10 0.00%
10/26/10 €26.10 0.00%
09/26/09 €26.10 0.00%
08/26/08 €26.10 0.00%
07/26/07 €26.10 +0.77%

Annual profits - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!